Atomoxetine could improve intra-individual variability in drug-naïve adults with attention-deficit/hyperactivity disorder comparably with methylphenidate: A head-to-head randomized clinical trial

Conclusion:
Our results provide evidence to support that atomoxetine could improve IIV-RT and inhibitory control, of comparable efficacy with immediate-release methylphenidate, in drug-naïve adults with ADHD. Shared and unique mechanisms underpinning these medication effects on IIV-RT awaits further investigation.

Source: Journal of Psychopharmacology - April 18, 2016 Category: Psychiatry Authors: Ni, H.-C., Hwang Gu, S.-L., Lin, H.-Y., Lin, Y.-J., Yang, L.-K., Huang, H.-C., Gau, S. S.-F. Tags: Original Papers Source Type: research